K

M

Mirae Asset Venture Investment

Crunchbase
Pitchbook
Crunchbase

Deals on record

7

Common Fundraising Type

Series B

A
ACT-ion

Battery technology • Lithium battery

Mirae Asset Capital logo
LG Technology Ventures logo
Hunt Energy Enterprises logo
BASF Venture Capital logo

ACT-ion is a battery technology company specializing in the production of coated single crystal lithium battery cathode active materials through an energy and cost-efficient process.

Series A
$7.5M
02/10/2025
Article
8
858 Therapeutics

Biotechnology • Small molecule therapeutics

Avidity Partners logo
Versant Ventures logo
NEA logo
Mirae Asset Capital logo

858 Therapeutics is a biotechnology company developing small molecule therapeutics for oncology and immunology, with a lead asset, ETX-19477, in Phase 1 trials for advanced solid tumors.

Series B
$50M
09/26/2024
Article
S
Sri Mandir

Devotional app • Virtual prayers

Susquehanna Asia VC logo
Peak XV logo
Mirae Asset VC logo
Fundamentum Partnership logo

AppsForBharat develops and operates Sri Mandir, a devotional app that facilitates virtual prayers, donations, and religious tourism, primarily targeting the Indian and Indian-American communities.

Series B
$18M
09/10/2024
Article
O
ON

AI chat platform • Generative AI

Mirae Asset Venture Investment logo
Equiam logo
Commonwealth Financial Network logo
B3 Capital logo

ON is a San Francisco-based AI chat platform that specializes in delivering generative AI experiences to major brands and sports teams, and is expanding into e-commerce, consumer banking, healthcare, and publishing sectors.

Equity
$25M
12/06/2023
Article
R
ROME Therapeutics

Biotechnology • Autoimmune Diseases

Section 32 logo
Sanofi Ventures logo
Raycap logo
Mirae Asset Capital logo

ROME Therapeutics is a biotechnology company that develops breakthrough medicines for serious diseases, with a focus on an inhibitor of LINE-1 reverse transcriptase for autoimmune diseases, using their proprietary data science platform to identify active repeat elements and assess their roles in disease.

Series B
$72M
09/12/2023
Article
d
d-Matrix

Generative AI • Data Centers

Playground Global logo
M12 logo
TGC Square logo
Temasek logo

d-Matrix is a company that develops generative AI compute solutions for data centers, specifically focusing on addressing memory bottlenecks and reducing AI compute costs through its Digital-In Memory Compute (DIMC) chiplet-based inference compute platform.

Series B
$110M
09/06/2023
Article
S
Sapeon

AI Semiconductor • Hyper-Cloud Processor

We Ventures logo
Mirae Asset Venture Investment logo
Hana Financial Group logo
E1 logo

Sapeon is a South Korea-based AI semiconductor company that develops a hyper-cloud AI processor designed to efficiently process large amounts of data simultaneously while using less power.

Series A
$45M
09/01/2023
Article